<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_source=Chrome
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_source=Chrome" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 25 Mar 2025 12:21:56 +0000</lastbuilddate>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130322/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: We demonstrate a cardioprotective mechanism regulating myocardial lipid homeostasis. The findings provide a promising therapeutic target to prevent and treat HfpEF, a condition with limited treatment options.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25. doi: 10.1161/CIRCULATIONAHA.124.072194. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Morbidity and mortality of heart failure with preserved ejection fraction (HFpEF) is increased in metabolic disorders. However, options for preventing and treating these prevalent outcomes are limited. Intramyocardial lipotoxicity contributes to cardiac dysfunction. Here, we investigate the mechanisms underlying endoplasmic reticulum degradation enhancing EDEM2 (endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 2) regulation of cardiac lipid homeostasis and assess strategies that inhibit the incidence and progression of HFpEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Metabolic stress was induced in C57BL/6 male mice using a high-fat diet and Nω-nitro-l-arginine methyl ester. The recombinant adeno-associated virus 9 delivery system was used for loss- and gain-of-function studies. Palmitic acid and oleic acid stimulation of rat cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes imitated a condition of high lipids in vitro. Molecular mechanisms were investigated via RNA sequencing, mass spectrometry proteomics, lipidomic analyses, transmission electron microscopy, histology, and luciferase reporter assays.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In the human heart, we first detected lipid overload accompanied by a reduction of XBP1 (X-box binding protein 1) under metabolic stress. Thereafter, a decrease in EDEM2 was confirmed in human and mouse HFpEF hearts. Given that the spliced form of XBP1 (XBP1s) is a transcription factor, EDEM2 was identified as its new target in cardiomyocytes. EDEM2 knockdown mice manifested lipid droplet accumulation and higher levels of triglycerides and diglycerides in the myocardium, aggravating oxidative stress, hypertrophy, and the onset and progression of HFpEF under metabolic stress. XBP1s ablation mice displayed a similar myocardial lipid disturbance and cardiac phenotypes, which were reversed by EDEM2 overexpression. Mechanistically, the findings obtained from rat cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes demonstrated that, in the presence of EDEM2, SEC23A mediated intracellular translocation of ATGL (adipose triglyceride lipase) under fatty acid stimulation, inhibiting ATGL degradation and excessive intracellular lipid droplets. Furthermore, the functional studies supported that EDEM2 prevention of lipid overload occurred in an ATGL-dependent manner. Therapeutically, cardiac XBP1s or EDEM2 restoration mitigated lipid deposition and preserved lipid profiles in the myocardium, thus preventing the development of HFpEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We demonstrate a cardioprotective mechanism regulating myocardial lipid homeostasis. The findings provide a promising therapeutic target to prevent and treat HfpEF, a condition with limited treatment options.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130322/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40130322</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072194>10.1161/CIRCULATIONAHA.124.072194</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130322</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Oveena Fonseka</dc:creator>
<dc:creator>Rida Raja</dc:creator>
<dc:creator>Claire Ross</dc:creator>
<dc:creator>Sanskruti R Gare</dc:creator>
<dc:creator>Jiayan Zhang</dc:creator>
<dc:creator>Susanne S Hille</dc:creator>
<dc:creator>Katharine King</dc:creator>
<dc:creator>Andrea Ruiz-Velasco</dc:creator>
<dc:creator>Namrita Kaur</dc:creator>
<dc:creator>Xinyi Chen</dc:creator>
<dc:creator>Jessica M Miller</dc:creator>
<dc:creator>Riham R E Abouleisa</dc:creator>
<dc:creator>Qinghui Ou</dc:creator>
<dc:creator>Zhiyong Zou</dc:creator>
<dc:creator>Xiangjun Zhao</dc:creator>
<dc:creator>Cristian Sotomayor-Flores</dc:creator>
<dc:creator>Derk Frank</dc:creator>
<dc:creator>Eileithyia Swanton</dc:creator>
<dc:creator>Martin R Pool</dc:creator>
<dc:creator>Sara Missaglia</dc:creator>
<dc:creator>Daniela Tavian</dc:creator>
<dc:creator>Gabriele G Schiattarella</dc:creator>
<dc:creator>Tao Wang</dc:creator>
<dc:creator>Luigi Venetucci</dc:creator>
<dc:creator>Christian Pinali</dc:creator>
<dc:creator>Martin K Rutter</dc:creator>
<dc:creator>Bernard D Keavney</dc:creator>
<dc:creator>Elizabeth J Cartwright</dc:creator>
<dc:creator>Tamer M A Mohamed</dc:creator>
<dc:creator>Oliver J Müller</dc:creator>
<dc:creator>Wei Liu</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity</dc:title>
<dc:identifier>pmid:40130322</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072194</dc:identifier>
</item>
<item>
<title>Local DIO2 Elevation Is an Adaption in Malformed Cerebrovasculature</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130314/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: We delineate a novel DIO2-mediated adaption in malformed cerebrovasculature and conclude that targeting TH signaling may represent a potential therapy for cerebrovascular disorders.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 25. doi: 10.1161/CIRCRESAHA.124.325857. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Cerebrovascular malformations are a pivotal cause of hemorrhage and neurological disability alongside lacking effective medication. Thyroid hormones (THs), including thyroxine and triiodothyronine, are essential for vascular development, yet whether they participate in malformed cerebrovascular pathology remains elusive.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Single-cell transcriptome analysis characterized human cerebral cavernous malformations and brain arteriovenous malformations, 2 typical cerebrovascular malformation diseases. Adeno-associated virus-mediated DIO2 (iodothyronine deiodinase 2; an enzyme that converts thyroxine to active triiodothyronine) overexpression/knockdown or triiodothyronine/methimazole (an antithyroid drug) treatment was applied to mouse models of cerebral cavernous malformations (endothelial-specific <i>Pdcd10</i> knockout mice, <i>Pdcd10</i> KO) and brain arteriovenous malformations (endothelial-specific <i>Kras</i><sup><i>G12D</i></sup> mutant mice, <i>Kras</i><sup><i>G12D</i></sup>) to evaluate the involvement of DIO2 and TH signaling in cerebrovascular malformations.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: TH signaling was markedly activated in fibroblasts of human cerebral cavernous malformation and arteriovenous malformation single-cell samples, accompanied by elevated DIO2 expression. Similar DIO2 upregulation was observed in cerebrovascular fibroblasts of <i>Pdcd10</i> KO/<i>Kras</i><sup><i>G12D</i></sup> mice and patient brain sections. Exogenous DIO2 or triiodothyronine replenishment effectively reduced brain hemorrhage, excessive ECM (extracellular matrix) remodeling, and vascular leakage in juvenile and adult male and female <i>Pdcd10</i> KO/<i>Kras</i><sup><i>G12D</i></sup> mice. In contrast, DIO2 silencing or TH inhibition deteriorated vascular anomalies. Mechanistically, transcription factor Foxk1 (forkhead box K1) was determined to interact with the <i>DIO2</i> promoter region. The activation of fibroblast PI3K-Akt-mTOR signaling in <i>Pdcd10</i> KO/<i>Kras</i><sup><i>G12D</i></sup> mice triggered Foxk1 nuclear translocation to promote <i>DIO2</i> transcription. Triiodothyronine treatment mitigated inflammatory infiltration, normalized mitochondrial morphology, and restored mitochondrial biogenesis in malformed brain vessels by activating the Pgc1a (peroxisome proliferator-activated receptor gamma coactivator 1-alpha)-Sod2 (superoxide dismutase 2)/Prdx3 (peroxiredoxin 3)/Gpx1 (glutathione peroxidase 1) axis to reduce reactive oxygen species accumulation. We also determined that the vascular repair effects of triiodothyronine were Pgc1a-dependent.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We delineate a novel DIO2-mediated adaption in malformed cerebrovasculature and conclude that targeting TH signaling may represent a potential therapy for cerebrovascular disorders.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130314/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40130314</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325857>10.1161/CIRCRESAHA.124.325857</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130314</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Ruofei Li</dc:creator>
<dc:creator>Yushan Tang</dc:creator>
<dc:creator>Haiyue Wang</dc:creator>
<dc:creator>Pengyan Hu</dc:creator>
<dc:creator>Liang Yu</dc:creator>
<dc:creator>Cheng Lv</dc:creator>
<dc:creator>Yu Zhang</dc:creator>
<dc:creator>A Martin Gerdes</dc:creator>
<dc:creator>Yibo Wang</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Local DIO2 Elevation Is an Adaption in Malformed Cerebrovasculature</dc:title>
<dc:identifier>pmid:40130314</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325857</dc:identifier>
</item>
<item>
<title>Valve-in-Valve TAVR in Patients With Failed Trifecta Bioprosthetic Aortic Valves</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130310/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Cardiovasc Interv. 2025 Mar 25:e014532. doi: 10.1161/CIRCINTERVENTIONS.124.014532. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130310/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40130310</a> | DOI:<a href=https://doi.org/10.1161/CIRCINTERVENTIONS.124.014532>10.1161/CIRCINTERVENTIONS.124.014532</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130310</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Mohammad Zmaili</dc:creator>
<dc:creator>Nikolaos Spilias</dc:creator>
<dc:creator>Shivabalan Kathavarayan Ramu</dc:creator>
<dc:creator>Tikal Kansara</dc:creator>
<dc:creator>Akhilesh Khuttan</dc:creator>
<dc:creator>Maryam Muhammad Ali Majeed-Saidan</dc:creator>
<dc:creator>Besir Besir</dc:creator>
<dc:creator>Rohan Prasad</dc:creator>
<dc:creator>Judah Rajendran</dc:creator>
<dc:creator>Feras Alkhalaileh</dc:creator>
<dc:creator>Ahmad Gharaibeh</dc:creator>
<dc:creator>Agam Bansal</dc:creator>
<dc:creator>Abdelrahman Abushouk</dc:creator>
<dc:creator>Serge Harb</dc:creator>
<dc:creator>Rishi Puri</dc:creator>
<dc:creator>Grant Reed</dc:creator>
<dc:creator>James Yun</dc:creator>
<dc:creator>Amar Krishnaswamy</dc:creator>
<dc:creator>Samir Kapadia</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation. Cardiovascular interventions</dc:source>
<dc:title>Valve-in-Valve TAVR in Patients With Failed Trifecta Bioprosthetic Aortic Valves</dc:title>
<dc:identifier>pmid:40130310</dc:identifier>
<dc:identifier>doi:10.1161/CIRCINTERVENTIONS.124.014532</dc:identifier>
</item>
<item>
<title>Many Journeys Originating at the Same Source to Arrive at Solutions to the Common Problem of High Lipoprotein(a)</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130305/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Genom Precis Med. 2025 Mar 25:e005126. doi: 10.1161/CIRCGEN.125.005126. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130305/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40130305</a> | DOI:<a href=https://doi.org/10.1161/CIRCGEN.125.005126>10.1161/CIRCGEN.125.005126</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130305</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Jean Woody Luxama</dc:creator>
<dc:creator>Joshua W Knowles</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation. Genomic and precision medicine</dc:source>
<dc:title>Many Journeys Originating at the Same Source to Arrive at Solutions to the Common Problem of High Lipoprotein(a)</dc:title>
<dc:identifier>pmid:40130305</dc:identifier>
<dc:identifier>doi:10.1161/CIRCGEN.125.005126</dc:identifier>
</item>
<item>
<title>Patient-Scientist Perspective on Developing Genetic Therapies for Marfan Syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130304/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Genom Precis Med. 2025 Mar 25:e005114. doi: 10.1161/CIRCGEN.125.005114. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130304/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40130304</a> | DOI:<a href=https://doi.org/10.1161/CIRCGEN.125.005114>10.1161/CIRCGEN.125.005114</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130304</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Lauren Testa</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation. Genomic and precision medicine</dc:source>
<dc:title>Patient-Scientist Perspective on Developing Genetic Therapies for Marfan Syndrome</dc:title>
<dc:identifier>pmid:40130304</dc:identifier>
<dc:identifier>doi:10.1161/CIRCGEN.125.005114</dc:identifier>
</item>
<item>
<title>Combined RNA Splicing and Patch-Clamp Analysis Reveal Pathogenicity of Splice-Altering Variants in &lt;em>;KCNH2&lt;/em>;-Related LQTS</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40130303/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Genom Precis Med. 2025 Mar 25:e004966. doi: 10.1161/CIRCGEN.124.004966. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40130303/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40130303</a> | DOI:<a href=https://doi.org/10.1161/CIRCGEN.124.004966>10.1161/CIRCGEN.124.004966</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40130303</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Susan Clasper</dc:creator>
<dc:creator>Gunjan Trivedi</dc:creator>
<dc:creator>Kate L Thomson</dc:creator>
<dc:creator>Claire L S Turner</dc:creator>
<dc:creator>Smrithi Devaiah</dc:creator>
<dc:creator>Catherine L Mercer</dc:creator>
<dc:creator>Amnah Y Bdeir</dc:creator>
<dc:creator>Jumana Y Al-Aama</dc:creator>
<dc:creator>Khalid Dagriri</dc:creator>
<dc:creator>Alex R Hobson</dc:creator>
<dc:creator>Shankar N Sadagopan</dc:creator>
<dc:creator>Julian Ormerod</dc:creator>
<dc:creator>Eszter Szepesvary</dc:creator>
<dc:creator>Justin Phan</dc:creator>
<dc:creator>Diane Fatkin</dc:creator>
<dc:creator>Jamie I Vandenberg</dc:creator>
<dc:creator>Zahurul A Bhuiyan</dc:creator>
<dc:creator>Chai-Ann Ng</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>Circulation. Genomic and precision medicine</dc:source>
<dc:title>Combined RNA Splicing and Patch-Clamp Analysis Reveal Pathogenicity of Splice-Altering Variants in &lt;em>;KCNH2&lt;/em>;-Related LQTS</dc:title>
<dc:identifier>pmid:40130303</dc:identifier>
<dc:identifier>doi:10.1161/CIRCGEN.124.004966</dc:identifier>
</item>
<item>
<title>Is altitude friend or foe in unrepaired congenital heart disease? A case report</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40129532/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>BACKGROUND: Some unrestrictive congenital shunts put patients at high risk for developing irreversible pulmonary vascular disease if not closed in the first year of life. Living at high altitude also places patients at risk for developing pulmonary hypertension. There are anecdotal data that living at high altitude may be protective against the development of shunt-related pulmonary vascular disease.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 24;9(3):ytaf115. doi: 10.1093/ehjcr/ytaf115. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Some unrestrictive congenital shunts put patients at high risk for developing irreversible pulmonary vascular disease if not closed in the first year of life. Living at high altitude also places patients at risk for developing pulmonary hypertension. There are anecdotal data that living at high altitude may be protective against the development of shunt-related pulmonary vascular disease.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE SUMMARY: A 20-year-old female from Ecuador was found to have a large patent ductus arteriosus (PDA) and pulmonary hypertension after a murmur was auscultated. She had been living at altitude until 6 months prior. She was found to have a large PDA, systemic pulmonary artery (PA) pressure, and an elevated pulmonary vascular resistance index (PVRi) (33 wu ∗ m<sup>2</sup>) with minimal shunting (Qp:Qs 1:1). Vasodilatory testing with inhaled nitric oxide (iNO) and 100% FiO2 showed continued systemic PA pressure but a dramatic decrease in PVRi (12.5 wu ∗ m<sup>2</sup>) with an increase in left-to-right shunt (Qp:Qs 2:1). Living at high altitude causes hypoxic vasoconstriction. This vasoconstriction, which is typically reversible on descent to sea level, may decrease the left-to-right shunt and the irreversible downstream vascular changes that would normally occur in the setting of an unrestrictive PDA. Given the significant acute drop of this patient's vascular resistance with pulmonary vasodilator testing, she was started on oral pulmonary vasodilators. However, months later, the patient became increasingly symptomatic and repeat catheterization showed worsening cardiac function. Pulmonary vasodilators were stopped and the decision was made not to close the PDA.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DISCUSSION: Living at high altitude may be protective against the development of congenital shunt-related irreversible pulmonary vascular disease. However, in this case, it may not have been enough due to the complexity of anatomy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40129532/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40129532</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11931610/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">PMC11931610</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf115>10.1093/ehjcr/ytaf115</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40129532</guid>
<pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Rebecca Fisher</dc:creator>
<dc:creator>Kali Hopkins</dc:creator>
<dc:creator>Krittika Pant</dc:creator>
<dc:creator>Arjun Kapoor</dc:creator>
<dc:creator>Ali N Zaidi</dc:creator>
<dc:date>2025-03-25</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Is altitude friend or foe in unrepaired congenital heart disease? A case report</dc:title>
<dc:identifier>pmid:40129532</dc:identifier>
<dc:identifier>pmc:PMC11931610</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf115</dc:identifier>
</item>
<item>
<title>Differences in Pediatric and Adult Heart Allocation Policies and Some of the Reasons Why</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127160/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):825-827. doi: 10.1161/CIRCULATIONAHA.125.072978. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127160/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40127160</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.072978>10.1161/CIRCULATIONAHA.125.072978</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127160</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Ryan R Davies</dc:creator>
<dc:creator>Maryjane Farr</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Differences in Pediatric and Adult Heart Allocation Policies and Some of the Reasons Why</dc:title>
<dc:identifier>pmid:40127160</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.072978</dc:identifier>
</item>
<item>
<title>Letter by Xu et al Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127159/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):e765. doi: 10.1161/CIRCULATIONAHA.124.072061. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127159/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40127159</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072061>10.1161/CIRCULATIONAHA.124.072061</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127159</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Lingyu Xu</dc:creator>
<dc:creator>Yanfei Wang</dc:creator>
<dc:creator>Yan Xu</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Xu et al Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</dc:title>
<dc:identifier>pmid:40127159</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072061</dc:identifier>
</item>
<item>
<title>Response by Zhao et al to Letters Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127158/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):e766. doi: 10.1161/CIRCULATIONAHA.125.073361. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127158/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40127158</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073361>10.1161/CIRCULATIONAHA.125.073361</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127158</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Di Zhao</dc:creator>
<dc:creator>Eliseo Guallar</dc:creator>
<dc:creator>Bruce A Wasserman</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Zhao et al to Letters Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</dc:title>
<dc:identifier>pmid:40127158</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.073361</dc:identifier>
</item>
<item>
<title>Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127157/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>Hypertension is the leading modifiable risk factor for atrial fibrillation (AF) and is estimated to be present in >;70% of AF patients. This Frontiers Review was prepared by 29 expert members of the AF-SCREEN International Collaboration to summarize existing evidence and knowledge gaps on links between hypertension, AF, and their cardiovascular sequelae; simultaneous screening for hypertension and AF; and the prevention of AF through antihypertensive therapy. Hypertension and AF are inextricably...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):863-877. doi: 10.1161/CIRCULATIONAHA.124.071047. Epub 2025 Mar 24.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Hypertension is the leading modifiable risk factor for atrial fibrillation (AF) and is estimated to be present in >;70% of AF patients. This Frontiers Review was prepared by 29 expert members of the AF-SCREEN International Collaboration to summarize existing evidence and knowledge gaps on links between hypertension, AF, and their cardiovascular sequelae; simultaneous screening for hypertension and AF; and the prevention of AF through antihypertensive therapy. Hypertension and AF are inextricably connected. Both are easily diagnosed, often silent, and frequently treated inadequately. Together, they additively increase the risk of ischemic stroke, heart failure, and many types of dementia, resulting in greater all-cause mortality, considerable disease burden, and increased health care expenditures. Automated upper arm cuff blood pressure devices with implemented technology can be used to simultaneously detect both hypertension and AF. However, positive screening for AF with an oscillometric blood pressure monitor still requires ECG confirmation. The current evidence suggests that high-risk individuals aged ≥65 years or with treatment-resistant hypertension could benefit from AF screening. Since antihypertensive therapy effectively lowers AF risk, particularly in individuals with left ventricular dysfunction, hypertension should be the key target for AF prediction and prevention rather than merely a comorbidity of AF. Nevertheless, several important gaps in knowledge need to be filled over the next years, including the ideal method and selection of patients for simultaneous screening of hypertension and AF and the optimal antihypertensive drug class and blood pressure targets for AF prevention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127157/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40127157</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071047>10.1161/CIRCULATIONAHA.124.071047</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127157</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Teemu J Niiranen</dc:creator>
<dc:creator>Renate B Schnabel</dc:creator>
<dc:creator>Aletta E Schutte</dc:creator>
<dc:creator>Yitschak Biton</dc:creator>
<dc:creator>Giuseppe Boriani</dc:creator>
<dc:creator>Claire Buckley</dc:creator>
<dc:creator>Alan C Cameron</dc:creator>
<dc:creator>Albertino Damasceno</dc:creator>
<dc:creator>Søren Z Diederichsen</dc:creator>
<dc:creator>Wolfram Doehner</dc:creator>
<dc:creator>Yutao Guo</dc:creator>
<dc:creator>F D Richard Hobbs</dc:creator>
<dc:creator>Boyoung Joung</dc:creator>
<dc:creator>Graeme J Hankey</dc:creator>
<dc:creator>Gregory Y H Lip</dc:creator>
<dc:creator>Trudie Lobban</dc:creator>
<dc:creator>Maja-Lisa Løchen</dc:creator>
<dc:creator>Georges Mairesse</dc:creator>
<dc:creator>Amam Mbakwem</dc:creator>
<dc:creator>Peter A Noseworthy</dc:creator>
<dc:creator>George Ntaios</dc:creator>
<dc:creator>Steven Steinhubl</dc:creator>
<dc:creator>George Stergiou</dc:creator>
<dc:creator>Jesper Hastrup Svendsen</dc:creator>
<dc:creator>Robert G Tieleman</dc:creator>
<dc:creator>Jiguang Wang</dc:creator>
<dc:creator>Neil R Poulter</dc:creator>
<dc:creator>Jeff S Healey</dc:creator>
<dc:creator>Ben Freedman</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration</dc:title>
<dc:identifier>pmid:40127157</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071047</dc:identifier>
</item>
<item>
<title>Letter by Wei and Yu Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127156/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):e764. doi: 10.1161/CIRCULATIONAHA.124.071784. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127156/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40127156</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071784>10.1161/CIRCULATIONAHA.124.071784</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127156</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Shouxin Wei</dc:creator>
<dc:creator>Sijia Yu</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Wei and Yu Regarding Article, "Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)"</dc:title>
<dc:identifier>pmid:40127156</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071784</dc:identifier>
</item>
<item>
<title>Clinical Interpretation of Statistical Interaction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127155/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):811-813. doi: 10.1161/CIRCULATIONAHA.125.073644. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127155/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40127155</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073644>10.1161/CIRCULATIONAHA.125.073644</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127155</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Andrea Bellavia</dc:creator>
<dc:creator>Sabina A Murphy</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Clinical Interpretation of Statistical Interaction</dc:title>
<dc:identifier>pmid:40127155</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.073644</dc:identifier>
</item>
<item>
<title>Coupling Interval Counts in Ventricular Premature Depolarizations During Acute Ischemia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127154/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):884-886. doi: 10.1161/CIRCULATIONAHA.124.073654. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127154/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40127154</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073654>10.1161/CIRCULATIONAHA.124.073654</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127154</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Yusuke Yamazaki</dc:creator>
<dc:creator>Hideo Mitamura</dc:creator>
<dc:creator>Toru Egashira</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Coupling Interval Counts in Ventricular Premature Depolarizations During Acute Ischemia</dc:title>
<dc:identifier>pmid:40127154</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073654</dc:identifier>
</item>
<item>
<title>Ganglionic Inflammation in a Patient With Takotsubo Syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127153/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):890-892. doi: 10.1161/CIRCULATIONAHA.124.070862. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127153/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40127153</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070862>10.1161/CIRCULATIONAHA.124.070862</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127153</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Karin A Ziegler</dc:creator>
<dc:creator>Manuel Zeitler</dc:creator>
<dc:creator>Sandro Meunier</dc:creator>
<dc:creator>Inga Sinicina</dc:creator>
<dc:creator>Tim P Hasenbein</dc:creator>
<dc:creator>Daniel Andergassen</dc:creator>
<dc:creator>Anton Bomhard</dc:creator>
<dc:creator>Reginald V C T van der Kwast</dc:creator>
<dc:creator>Stefan Engelhardt</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Ganglionic Inflammation in a Patient With Takotsubo Syndrome</dc:title>
<dc:identifier>pmid:40127153</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070862</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40127152/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Mar 25;151(12):878-883. doi: 10.1161/CIRCULATIONAHA.125.074426. Epub 2025 Mar 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40127152/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40127152</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.074426>10.1161/CIRCULATIONAHA.125.074426</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40127152</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:date>2025-03-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:40127152</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.074426</dc:identifier>
</item>
<item>
<title>Homogeneity of the Coronary Microcirculation in Angina with Non-Obstructive Coronary Artery Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40126977/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: In most ANOCA patients, microvascular function is homogeneously distributed across the three major coronary territories. Single-artery testing may suffice in many cases, aligning with guidelines. However, some patients exhibit notable inter-territorial variation, suggesting that multivessel evaluation may be prudent in borderline scenarios.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Cardiovasc Imaging. 2025 Mar 24:jeaf101. doi: 10.1093/ehjci/jeaf101. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: The homogeneity of coronary microcirculatory dysfunction (CMD) across different myocardial territories in angina with non-obstructive coronary artery disease (ANOCA) patients is scarcely explored. This study investigates the variability in microvascular resistance reserve (MRR) across the 3 main perfusion territories of the coronary circulation to investigate the homogeneity or dishomogeneity of microcirculatory function.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: This post-hoc analysis of the PACIFIC trials included symptomatic ANOCA patients with [15O]H2O positron emission tomography (PET) and three-vessel invasive fractional flow reserve (FFR). MRR was computed in the three main coronary branches by integrating PET-derived coronary flow reserve and invasive FFR. A total of 155 patients (50% male, age 59 ± 10 years) and 465 vessels (MRR: 3.92 ± 1.21) were included. There were no significant differences in MRR among the three coronary branches. Correlations in MRR among the three coronary branches were good (r = 0.76 to 0.86). The mean difference between MRR measurements in different arteries was small (2.4 to 7.5%), without any consistent directional bias. The overall intraclass correlation coefficient for absolute agreement was 0.80 (95% CI: 0.74-0.85), indicating good single-measure reliability. Approximately 80% (123/155) of patients showed diagnostic concordance of CMD (MRR ≤3.0) across the three vessels.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: In most ANOCA patients, microvascular function is homogeneously distributed across the three major coronary territories. Single-artery testing may suffice in many cases, aligning with guidelines. However, some patients exhibit notable inter-territorial variation, suggesting that multivessel evaluation may be prudent in borderline scenarios.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40126977/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40126977</a> | DOI:<a href=https://doi.org/10.1093/ehjci/jeaf101>10.1093/ehjci/jeaf101</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40126977</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Masahiro Hoshino</dc:creator>
<dc:creator>Roel Hoek</dc:creator>
<dc:creator>Ruurt A Jukema</dc:creator>
<dc:creator>Jorge Dahdal</dc:creator>
<dc:creator>Pepijn van Diemen</dc:creator>
<dc:creator>Pieter Raijmakers</dc:creator>
<dc:creator>Roel Driessen</dc:creator>
<dc:creator>Jos Twisk</dc:creator>
<dc:creator>Ibrahim Danad</dc:creator>
<dc:creator>Tsunekazu Kakuta</dc:creator>
<dc:creator>Juhani Knuuti</dc:creator>
<dc:creator>Paul Knaapen</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Cardiovascular Imaging</dc:source>
<dc:title>Homogeneity of the Coronary Microcirculation in Angina with Non-Obstructive Coronary Artery Disease</dc:title>
<dc:identifier>pmid:40126977</dc:identifier>
<dc:identifier>doi:10.1093/ehjci/jeaf101</dc:identifier>
</item>
<item>
<title>Successful percutaneous retrieval of a detached MitraClip® in the left atrium via maintained gripper line: a case report</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124626/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>BACKGROUND: Mitral valve transcatheter edge-to-edge repair (M-TEER) with MitraClip® has become an established treatment for high-risk patients with mitral regurgitation (MR). While device-related complications are known, they typically occur during leaflet grasping or after deployment, with most issues arising from device-tissue interaction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 8;9(3):ytaf124. doi: 10.1093/ehjcr/ytaf124. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Mitral valve transcatheter edge-to-edge repair (M-TEER) with MitraClip® has become an established treatment for high-risk patients with mitral regurgitation (MR). While device-related complications are known, they typically occur during leaflet grasping or after deployment, with most issues arising from device-tissue interaction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE SUMMARY: A 67-year-old woman with dilated cardiomyopathy underwent M-TEER for severe functional MR. Although resistance was noted during initial device preparation and loading, limited functional testing appeared normal and the procedure was continued. During clip manipulation in the left atrium, mechanical resistance in the arm positioner led to unexpected detachment of the MitraClip, connected only by the gripper line. Through careful traction under echocardiographic and fluoroscopic guidance, we successfully retrieved the clip percutaneously. The procedure was completed with new MitraClip systems, achieving mild residual MR. The patient's symptoms improved from New York Heart Association Classes II and III to I, with sustained improvement during 4.5 years of follow-up.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DISCUSSION: This case reveals a novel mechanism of MitraClip detachment through mechanical failure during preparation, where introducer damage led to harness deformation and subsequent clip detachment. Among available retrieval options, we demonstrated the feasibility of direct traction retrieval under specific conditions, offering a less invasive solution when gripper line connection is maintained. This case emphasizes the importance of meticulous device inspection and preparation, while providing insights into both failure mechanisms and retrieval strategies in M-TEER complications.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124626/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40124626</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11926327/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">PMC11926327</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf124>10.1093/ehjcr/ytaf124</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124626</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Hiroto Yagasaki</dc:creator>
<dc:creator>Takeki Suzuki</dc:creator>
<dc:creator>Ryota Watanabe</dc:creator>
<dc:creator>Keitaro Watanabe</dc:creator>
<dc:creator>Toshiyuki Noda</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Successful percutaneous retrieval of a detached MitraClip® in the left atrium via maintained gripper line: a case report</dc:title>
<dc:identifier>pmid:40124626</dc:identifier>
<dc:identifier>pmc:PMC11926327</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf124</dc:identifier>
</item>
<item>
<title>Percutaneous coronary intervention in anomalous aortic origin of a coronary artery: a rare case report of a dual-left anterior descending artery with a pre-pulmonary course</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124625/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: This case underscores the importance of CT scan in delineating the anatomical characteristics of AAOCA, and the feasibility and efficacy of PCI in symptomatic, non-high-risk AAOCA, emphasizing its role as a minimally invasive alternative within a multidisciplinary approach.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 3;9(3):ytaf112. doi: 10.1093/ehjcr/ytaf112. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Anomalous aortic origin of a coronary artery (AAOCA) of the left anterior descending artery (LAD) is a rare congenital anomaly. Their percutaneous coronary intervention (PCI) when an ischaemia is documented remains challenging.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE PRESENTATION: We report the case of a 52-year-old patient from Bangladesh with dual-origin LAD arising from both left and right sinus with a pre-pulmonary course, presenting with exertional angina and documented myocardial ischaemia. Computed tomography (CT) scan confirmed the anatomical course of the AAOCA. Percutaneous coronary intervention was successfully performed using tailored techniques to treat significant atherosclerotic lesions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This case underscores the importance of CT scan in delineating the anatomical characteristics of AAOCA, and the feasibility and efficacy of PCI in symptomatic, non-high-risk AAOCA, emphasizing its role as a minimally invasive alternative within a multidisciplinary approach.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124625/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40124625</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11925849/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">PMC11925849</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf112>10.1093/ehjcr/ytaf112</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124625</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Sara Jourani</dc:creator>
<dc:creator>Zakaria Laraichi</dc:creator>
<dc:creator>Mehdi Saighi Bouaouina</dc:creator>
<dc:creator>Cedric Gaultier</dc:creator>
<dc:creator>Hakim Benamer</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Percutaneous coronary intervention in anomalous aortic origin of a coronary artery: a rare case report of a dual-left anterior descending artery with a pre-pulmonary course</dc:title>
<dc:identifier>pmid:40124625</dc:identifier>
<dc:identifier>pmc:PMC11925849</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf112</dc:identifier>
</item>
<item>
<title>Bachmann's bundle and upper septal inter-atrial connections as key paths for a biatrial macro re-entrant circle: a case report</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124624/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>BACKGROUND: The Bachmann's bundle has been described as a key route for re-entrant circuits in biatrial tachycardias. Septal inter-atrial muscular connections were discovered a while ago, but evidence on their potential role in re-entrant tachycardias is lacking.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Case Rep. 2025 Mar 7;9(3):ytaf119. doi: 10.1093/ehjcr/ytaf119. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The Bachmann's bundle has been described as a key route for re-entrant circuits in biatrial tachycardias. Septal inter-atrial muscular connections were discovered a while ago, but evidence on their potential role in re-entrant tachycardias is lacking.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CASE SUMMARY: We describe an atrial macro re-entrant circuit presented as a wide complex tachycardia that utilized the Bachmann's bundle, septal inter-atrial connections, and a limited area of the anterior left atrial myocardium in a patient with previous multiple atrial fibrillation ablation procedures. This tachycardia was diagnosed by using a combination of electrophysiological visualization modalities and was terminated by a single radiofrequency application.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DISCUSSION: The inter-atrial muscular connections can pose a major contribution to the mechanism of biatrial tachycardias, especially in patients after extensive left atrial ablation. Thorough mapping modalities, including entrainment stimulation, facilitate a correct diagnosis. Understanding inter-atrial connection anatomy is crucial for the detection and successful ablation of such tachycardia.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124624/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40124624</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11925846/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">PMC11925846</a> | DOI:<a href=https://doi.org/10.1093/ehjcr/ytaf119>10.1093/ehjcr/ytaf119</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124624</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Heber Ivan Condori Leandro</dc:creator>
<dc:creator>Dmitry S Lebedev</dc:creator>
<dc:creator>Lubov B Mitrofanova</dc:creator>
<dc:creator>Evgeny N Mikhaylov</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Case reports</dc:source>
<dc:title>Bachmann's bundle and upper septal inter-atrial connections as key paths for a biatrial macro re-entrant circle: a case report</dc:title>
<dc:identifier>pmid:40124624</dc:identifier>
<dc:identifier>pmc:PMC11925846</dc:identifier>
<dc:identifier>doi:10.1093/ehjcr/ytaf119</dc:identifier>
</item>
<item>
<title>Shear wave elastography to unmask differences in myocardial stiffness between athletes and sedentary non-athletes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40124097/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250325082153&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: SW elastography reveals reduced myocardial stiffness in athletes compared to sedentary non-athletes at rest and during exercise, which is not detected by conventional echocardiographic measurements. Exercise-induced changes in SW velocities after AVC may potentially serve as an early marker for detecting diastolic dysfunction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Imaging Methods Pract. 2025 Mar 21;2(4):qyaf023. doi: 10.1093/ehjimp/qyaf023. eCollection 2024 Oct.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Myocardial stiffening naturally occurs with aging and contributes to diastolic dysfunction. Assessing myocardial stiffness non-invasively could improve the sensitivity of diastolic function evaluation in clinical practice. Shear wave (SW) elastography is a non-invasive tool for quantifying myocardial stiffness, where higher SW velocities indicate increased stiffness. We investigated whether SW elastography could detect differences in myocardial stiffness between athletes and sedentary non-athletes and, during exercise, reveal differences in operational stiffness that may indicate diastolic dysfunction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: We enrolled 20 master athletes (median age 60 [IQR 59-66] years) and 17 sedentary non-athletes (median age 58 [IQR 52-71] years). Standard exercise echocardiography revealed no significant differences in diastolic function between the groups. Additionally, ultra-high frame rate imaging was used to measure SW velocities after mitral valve closure (MVC) and aortic valve closure (AVC) at rest and during exercise. At rest, athletes had lower SW velocities after MVC compared to sedentary non-athletes (3.2 ± 0.4 m/s vs. 3.9 ± 0.7 m/s, respectively, <i>P</i> = 0.003). During exercise, SW velocities after AVC significantly increased in sedentary non-athletes but not in athletes (+1.6 ± 1.6 cm/s increase per 1% power output increase vs. 0.0 ± 0.8 cm/s, respectively, <i>P</i> = 0.006). An inverse correlation was found between the increase of SW velocity after AVC during exercise and VO<sub>2</sub>max (<i>r</i> = -0.51, <i>P</i> = 0.003).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: SW elastography reveals reduced myocardial stiffness in athletes compared to sedentary non-athletes at rest and during exercise, which is not detected by conventional echocardiographic measurements. Exercise-induced changes in SW velocities after AVC may potentially serve as an early marker for detecting diastolic dysfunction.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40124097/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">40124097</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11925635/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250325082153&v=2.18.0.post9+e462414">PMC11925635</a> | DOI:<a href=https://doi.org/10.1093/ehjimp/qyaf023>10.1093/ehjimp/qyaf023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40124097</guid>
<pubDate>Mon, 24 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Karim Taha</dc:creator>
<dc:creator>Youri Bekhuis</dc:creator>
<dc:creator>Ruben de Bosscher</dc:creator>
<dc:creator>Christophe Dausin</dc:creator>
<dc:creator>Marta Orlowska</dc:creator>
<dc:creator>Ahmed S Youssef</dc:creator>
<dc:creator>Stéphanie Bézy</dc:creator>
<dc:creator>Véronique Cornelissen</dc:creator>
<dc:creator>Lieven Herbots</dc:creator>
<dc:creator>Rik Willems</dc:creator>
<dc:creator>Jens-Uwe Voigt</dc:creator>
<dc:creator>Jan D'hooge</dc:creator>
<dc:creator>Guido Claessen</dc:creator>
<dc:date>2025-03-24</dc:date>
<dc:source>European heart journal. Imaging methods and practice</dc:source>
<dc:title>Shear wave elastography to unmask differences in myocardial stiffness between athletes and sedentary non-athletes</dc:title>
<dc:identifier>pmid:40124097</dc:identifier>
<dc:identifier>pmc:PMC11925635</dc:identifier>
<dc:identifier>doi:10.1093/ehjimp/qyaf023</dc:identifier>
</item>





























</channel>
</rss>